The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
about
Exercise training enhanced myocardial endothelial nitric oxide synthase (eNOS) function in diabetic Goto-Kakizaki (GK) ratsRedox mechanisms in hepatic chronic wound healing and fibrogenesisNetrin-1 as a novel therapeutic target in cardiovascular disease: to activate or inhibit?The role of platelets in the recruitment of leukocytes during vascular diseasePoly-s-nitrosated albumin as a safe and effective multifunctional antitumor agent: characterization, biochemistry and possible future therapeutic applicationsalpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic roleA short history of nitroglycerine and nitric oxide in pharmacology and physiologyRoles for both cyclic GMP and cyclic AMP in the inhibition of collagen-induced platelet aggregation by nitroprussideTherapeutic effects of nitric oxide-aspirin hybrid drugsMechanism of action of novel NO-releasing furoxan derivatives of aspirin in human plateletsAntiplatelet therapy in peripheral occlusive arterial diseaseA novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjectsNitric oxide synthases: regulation and functionProstaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man.Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharideNitric oxide induces Zn2+ release from metallothionein by destroying zinc-sulphur clusters without concomitant formation of S-nitrosothiolRole of ETB and B2 receptors in the ex vivo platelet inhibitory properties of endothelin and bradykinin in the mouseNeuronal nitric oxide synthase (NOS) regulates leukocyte-endothelial cell interactions in endothelial NOS deficient miceRole of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclinA new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acidCyclic AMP elevating agents and nitric oxide modulate angiotensin II-induced leukocyte-endothelial cell interactions in vivoSuccessful development of small diameter tissue-engineering vascular vessels by our novel integrally designed pulsatile perfusion-based bioreactorTherapeutic Potential of Transdermal Glyceryl Trinitrate in the Management of Acute Stroke.Neointimal hyperplasia associated with synthetic hemodialysis grafts.Decomposition of protein nitrosothiolsin matrix-assisted laser desorption/ionization and electrospray ionization mass spectrometry.Formation of S-nitrosothiols from regiospecific reaction of thiols with N-nitrosotryptophan derivatives.Water-soluble poly(ethylenimine)-based nitric oxide donors: preparation, characterization, and potential application in hemodialysis.Assessment of endothelial damage and cardiac injury in a mouse model mimicking thrombotic thrombocytopenic purpura.Pharmacology of endothelium-derived nitric oxide and nitrovasodilators.Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled.Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cellsCyclosporin treatment does not impair the release of nitric oxide in human coronary arteries.Nitric Oxide and Related Aspects Underlying Angina.Role of NAD(P)H oxidase in superoxide generation and endothelial dysfunction in Goto-Kakizaki (GK) rats as a model of nonobese NIDDM.Laser-induced endothelial cell activation supports fibrin formation.An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.Role for NADPH/NADH oxidase in the modulation of vascular tone.Endogenous nitric oxide synthesis: biological functions and pathophysiology.Nitric oxide in the pathogenesis of vascular disease.Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute ischaemic stroke.
P2860
Q21246036-EAD5E7B1-8185-4654-B0BC-86798D1C39B4Q24656684-2EB3407F-6C15-4708-93E2-11ADCA663677Q26799750-C181B238-8FD4-4504-BB33-70FD16E6F082Q26801407-92E2FADD-CCC3-4BF9-90E9-102A25277B4AQ26859056-537260DA-7673-475E-A3BA-E5E53E7607DDQ28142296-F33D2C3E-8923-4CF8-BD98-6F83C4441934Q28142777-74F41765-B0F5-41C9-A30B-9C06837AEEC8Q28193055-72996313-42F4-43EA-B3AA-F2D9B4340EE7Q28210282-D51E6728-DA07-46EB-8468-C033439AA9AFQ28218042-02214F7B-9F98-4FC0-A1F3-9A9162B7DE8BQ28219001-5FF5691B-D81F-4657-831E-6AFAD8BDC242Q28221564-6FAAC83E-3D75-4302-A5E3-B458546B57A0Q28247092-6EFE7BD3-E31F-40E5-AA97-6D2E7A31B338Q28319715-DF89DCDD-E0CE-43FF-A775-6BC6CC974B44Q28343043-A21B332C-8DA5-4695-868B-30E17DEF4DF8Q28343675-96419D10-92A1-438D-B423-D02B80A95D2AQ28349952-7B7D3C05-FF41-4919-A6FA-E8E43A6EA14FQ28357811-CB93E818-F469-4928-A489-132586E86833Q28362757-7B25B38F-28A4-4A66-9006-A3651E3D7A92Q28365858-1A7E318A-1044-4C1B-B59B-66251AE82778Q28366560-80136103-2AF0-4D34-8DC1-04E087B7CF87Q28482085-84FB4C8C-CB08-4965-B480-7C534A6BA9F0Q30490373-46653D9C-4849-46D9-A2BB-5FDDC70C6171Q30492883-7457EEE4-964A-493C-97E2-C675BF046D43Q30945382-63A1ADA4-D3D2-4546-8B3B-F0765A0A3D4BQ30952040-2B54D714-0485-414D-8419-16AD7C39CFCCQ31059963-D647C890-C33C-488B-B9EF-4EF312A26D51Q33434431-C17DA009-8ACB-434C-96BB-3491DE5EC9E2Q33558813-B07D86F8-D8DC-4D41-B4BB-845D33124FB9Q33564715-261CFB89-9573-44DE-95EE-1546FB41E6B1Q33567885-C90E45A2-2A33-4028-BD20-1592DFA8B938Q33611345-132714E3-FE8B-4D15-BA20-0CC5AF60D2D8Q33641341-2DAC6A39-696C-4493-A7D0-C1DEA0EA5DD0Q33644486-DDDC1C68-50ED-43BB-805E-E5D5017EA0ABQ33646447-E6472896-1E7C-427D-83C4-595C112D17C9Q33674149-9C9D6BA1-AC57-4E20-9992-E243729CB20CQ33692492-C5A761F9-66D6-4009-886D-2618A1F1A8FAQ33814359-65D365B3-C050-4A30-A0C3-D046EC3AA59EQ33843539-05B671EF-B3E4-40C8-8CBA-A31F45FCE37FQ33907931-0BDDB6CB-0903-4EAE-8BE5-BBF8C41F91DE
P2860
The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
The anti-aggregating propertie ...... prostacyclin and nitric oxide.
@en
The anti-aggregating propertie ...... prostacyclin and nitric oxide.
@nl
type
label
The anti-aggregating propertie ...... prostacyclin and nitric oxide.
@en
The anti-aggregating propertie ...... prostacyclin and nitric oxide.
@nl
prefLabel
The anti-aggregating propertie ...... prostacyclin and nitric oxide.
@en
The anti-aggregating propertie ...... prostacyclin and nitric oxide.
@nl
P2093
P2860
P1476
The anti-aggregating propertie ...... prostacyclin and nitric oxide.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1987.TB11367.X
P407
P577
1987-11-01T00:00:00Z